When we use androgen deprivation therapy, we are lowering testosterone levels typically by turning off the testes from making testosterone. This starves cancer cells, causing them to shut down, ...

So when my urologist said in 2019 that my PSA test showed the most aggressive form of prostate cancer, I was not prepared. I was 68, and my annual tests had always been normal. Soon I embarked on a ...

New insights highlight how prostate cancer is now managed as a chronic disease, with emerging treatments and real-world data ...

A recent trial reveals metformin does not enhance survival in metastatic prostate cancer but offers significant metabolic ...

Androgen deprivation therapy is commonly used to treat prostate cancer, often on an open-ended basis for therapy of advanced prostate cancer. It is estimated that 44 percent of men with prostate ...

It has been over 70 years since the initial description of prostate cancer androgen dependence by Huggins and Hodges leading to androgen deprivation becoming a mainstay treatment for the disease.

I am Sandy Srinivas and I'm the host of the Medscape InDiscussion podcast series on prostate cancer. Today we want to talk about bone health and survivorship with androgen deprivation therapy (ADT).

Androgen deprivation therapy (ADT) for prostate cancer is associated with decreased bone mineral density (BMD) in patients. This decreased BMD can lead to an increased risk of fractures and ...

CORRESPONDENCE June 01, 2018 Androgen-Deprivation Therapy Is More Than Palliation in Oligometastatic Prostate Cancer Authors: Carlo Cattrini [email protected], Elisa Zanardi, and Francesco ...

Therapeutic Rationale Androgens can drive prostate cancer growth, thus providing the rationale for using deprivation of androgens as a first line of treatment for prostate cancer. Unfortunately ...

"Androgen-deprivation therapy is commonly used to treat patients whose prostate cancer has spread beyond the prostate. While most men initially respond to this therapy, the cancer nearly always ...